Back to Search
JAMES THIGPEN, M.D.
M.D.
Family Medicine Physician
NPI: 1841369105IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
030228(GA)
Emergency Medicine Physician
Emergency Medicine
Code: 207P00000X
030228(GA)
Education
UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE
Class of 1986
Research & Publications (20)
American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.
PMID 19018081·J Clin Oncol·2009
8-other
Clinical trial endpoints in ovarian cancer: report of an FDA/ASCO/AACR Public Workshop.
PMID 17950384·Gynecol Oncol·2007
8-other
The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study.
PMID 17574073·Gynecol Oncol·2007
3-trial
Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
PMID 17502627·J Clin Oncol·2007
3-trial
Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study.
PMID 17150247·Gynecol Oncol·2007
3-trial
Variations in phytoestrogen content between different mill dates of the same diet produces significant differences in the time of vaginal opening in CD-1 mice and F344 rats but not in CD Sprague-Dawley rats.
PMID 18087589·Environ Health Perspect·2007
7-preclinical
Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group study.
PMID 17001661·Cancer·2006
8-other
The role of maintenance therapy and novel taxanes in ovarian cancer.
PMID 16460787·Gynecol Oncol·2006
6-review
Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
PMID 16330675·J Clin Oncol·2006
3-trial
Selecting the appropriate rodent diet for endocrine disruptor research and testing studies.
PMID 15454679·ILAR J·2004
6-review
Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study.
PMID 15459211·J Clin Oncol·2004
3-trial
Cisplatin as second-line therapy in ovarian carcinoma treated initially with single-agent paclitaxel: a Gynecologic Oncology Group study.
PMID 13678728·Gynecol Oncol·2003
3-trial
Dietary phytoestrogens accelerate the time of vaginal opening in immature CD-1 mice.
PMID 14727808·Comp Med·2003
7-preclinical
Developmental considerations for resuscitation of the VLBW infant.
PMID 12078318·Neonatal Netw·2002
6-review
Dietary factors affecting uterine weights of immature CD-1 mice used in uterotrophic bioassays.
PMID 12518869·Cancer Detect Prev·2002
7-preclinical
Effects of the dietary phytoestrogens daidzein and genistein on the incidence of vulvar carcinomas in 129/J mice.
PMID 12132873·Cancer Detect Prev·2001
7-preclinical
Reliability assessment of soluble c-erbB-2 concentrations in the saliva of healthy women and men.
PMID 11174594·Oral Surg Oral Med Oral Pathol Oral Radiol Endod·2001
4-observational
Chemotherapy for advanced ovarian cancer: overview of randomized trials.
PMID 10952121·Semin Oncol·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3448 VINEVILLE AVE
MACON, GA 31204 - Phone
- (478) 405-0045
Quick Facts
- NPI
- 1841369105
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 40
- Publications
- 20
Are you this provider?
Claim Your Profile